Skip to main content
SB

Sparta Biomedical

Sparta Biomedical is developing Galene, a chemically engineered cartilage platform that provides cartilage-like implants for knee and other joints, enabling immediate pain reduction and restoration of full range of motion. The company addresses the significant issue of cartilage degeneration in osteoarthritis patients, offering a solution that allows for quicker recovery and improved quality of life compared to existing treatments.

Madison, United StatesFounded 20176500+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Osteoarthritis and cartilage defects lead to significant pain and limited range of motion in joints, affecting a large portion of the global population. Current treatments for cartilage damage have limitations, including lengthy recovery times and dependence on the patient's own biology for regeneration. Existing surgical treatments often fall short of providing immediate pain relief and restoring full joint function.

Solution

Sparta Biomedical is developing Galene, a chemically engineered cartilage platform designed to provide cartilage-like implants for knee and other joints. Galene aims to address the limitations of current cartilage repair techniques by offering immediate pain reduction and restoration of full range of motion. Unlike cartilage regeneration technologies that require months or years for cartilage to fully regenerate, Galene replicates the physical properties of native human hyaline cartilage immediately. The company's lead product, Ormi™, combines Galene with an osseointegrative titanium base to treat chondral and osteochondral lesions of the femoral condyle.

Target Audience

The primary target audience includes individuals suffering from osteoarthritis and cartilage defects, as well as orthopedic surgeons seeking advanced solutions for joint repair.

Features

  • Chemically engineered cartilage platform (Galene) that replicates the physical properties of native human hyaline cartilage
  • Ormi™ implant, combining Galene with an osseointegrative titanium base for treating chondral and osteochondral lesions
  • Optimized geometry based on anatomical locations to precisely address patient needs
  • Potential for immediate pain reduction and restoration of full range of motion
  • Pipeline of Ormi™ solutions for various indications, including femoral condyle, patella, trochlea, CMC, MTP, shoulder, hip, elbow, and talus
This profile is AI-generated and may contain inaccuracies.